AV
Atlas Venture Life Science Advisors, LLC
CAMBRIDGE MA · SEC CIK 0001917529
$881.29M2026Q2 reported value
7Positions
100.0%Top 10 weight · largest 37.1%
0 / 0New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
QTTB Added+$7.96M
2026Q2 top sells estimated at quarter-end value
KYMR Reduced-$198.43M
DYN Reduced-$51.76M
KRRO Reduced-$2.30M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | $326.53M | 37.05% | 2,847,541 | -1,730,467 | -37.8% | -$198.43M | Reduced |
| DYN | Dyne Therapeutics, Inc. | $151.03M | 17.14% | 6,800,099 | -2,330,366 | -25.5% | -$51.76M | Reduced |
| SION | Sionna Therapeutics, Inc. | $131.78M | 14.95% | 2,995,602 | 0 | 0.0% | — | Unchanged |
| KLRA | Kailera Therapeutics, Inc. | $113.92M | 12.93% | 5,171,282 | 5,171,282 | — | — | First reported |
| IRON | Disc Medicine, Inc. | $110.72M | 12.56% | 1,513,875 | 0 | 0.0% | — | Unchanged |
| QTTB | Q32 Bio, Inc. | $34.62M | 3.93% | 2,717,106 | 625,000 | 29.9% | $7.96M | Added |
| KRRO | Korro Bio, Inc. | $12.69M | 1.44% | 962,884 | -174,265 | -15.3% | -$2.30M | Reduced |